April 29, 2019 / 12:10 PM / 3 months ago

CORRECTED-(OFFICIAL)-BRIEF-Yichang Hec Changjiang Pharmaceutical Posts QTRLY Net Profits Attributable RMB924.1 MLN (April 26)

(Corrects FY net profit to RMB 924.1 mln from RMB775.5 mln in headline and second bullet)

April 26 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd:

* QTRLY OPERATING REVENUE RMB1,905.2 MILLION

* Q1 NET PROFITS ATTRIBUTABLE TO SHAREHOLDERS OF PARENT COMPANY OF RMB924.1 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below